Un-blinded Data Collection Study of Concussion Using the BrainPulse(TM)

Mild Traumatic Brain Injury Clinical Trial

Official title:

Non-Blinded Data Collection Study Of Concussion Using The BrainPulse

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02849002
• Other study ID #: JMC-1601-P01
• Status: Terminated
• Start date: July 14, 2016
• Est. completion date: September 29, 2016

Study information

• Verified date: July 2023
• Source: Jan Medical, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The primary objective of this study is to collect un-blinded BrainPulse recordings from youth and adults that have a confirmed diagnosis of concussion per protocol guidelines in order to improve a concussion detection algorithm previously developed by Jan Medical, Inc. Subjects will be followed for 21 days after the initial injury with BrainPulse recordings to study the subject's recovery process. The symptomatic evaluation, physical examination, and BrainPulse recordings will be entered in a database to assess clinical outcome and device utilization.BrainPulse(TM)

Description:

Jan Medical is conducting a data collection study with the goal of developing further insight into understanding the signal features within a BrainPulse recording that are only present when the subject has a confirmed concussion. The initial pilot blinded study with Stanford University showed that there is increased energy in the 8-15 Hz range for BrainPulse recordings from adolescent male football players with a confirmed concussion. The current un-blinded study is designed to record the BrainPulse signal from a more diverse subject population to represent patients who have been diagnosed with a concussion in clinic setting. Subjects will include males and females ages 13 and older.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 25
• Est. completion date: September 29, 2016
• Est. primary completion date: September 29, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 13 Years and older

Eligibility

Inclusion Criteria:

1. Age > 13 years old and not part of any other vulnerable population such as pregnant women.

2. Suspected or confirmed concussion by medical professional

3. Not more than 3 days since injury/trauma event

4. Willing and able to participate in all required study evaluations and allow access to medical testing and records

5. Signed informed consent/assent, and/or have a legally authorized representative willing to provide informed consent on behalf of the subject.

6. Demonstrates a minimum of 3 of the following symptoms:

• Headache
• Pressure in head
• Dizziness
• Neck pain
• Fatigue/ low energy
• Nausea or vomiting
• Irritability
• Difficulty in concentrating/performing tasks
• Memory impairment
• Insomnia
• Reduced tolerance to stress
• Sensitivity to light
• Difficulty balancing
• Blurred vision
• Confusion
• More emotional than usual
• Sadness
• Nervous/Anxious
• Vacant stare
• Delayed verbal/motor response
• 'Feeling like in a fog'
• 'Don't feel right'

Exclusion Criteria:

1. Wound or open laceration on the head in the area of one of the BrainPulse sensors that would impede use of the BrainPulse device

2. Any serious medical condition that in the opinion of the medical professional would impair ability to provide informed consent/assent or otherwise disqualify a patient from participation

3. Currently participating in or planning to participate in another clinical study during the course of the current clinical study.

4. Implantation of any medical device in head (e.g. ventriculoperitoneal shunt)

5. An alternative diagnosis is made other than concussion

Related Conditions & MeSH terms

• Brain Concussion
• Brain Injuries
• Brain Injuries, Traumatic
• Mild Traumatic Brain Injury

Intervention

Device:
• BrainPulse
Jan Medical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle, referred to as the BrainPulse signal. The BrainPulse measures skull acceleration in response to the brain motion using an array of sensors placed on the head.

Locations

Country	Name	City	State
Canada	Konkussion Inc.	Woodbridge	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Jan Medical, Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of BrainPulse recordings from suspected and confirmed concussed subjects	collect un-blinded BrainPulse recordings from youth and adults that have a confirmed diagnosis of concussion per protocol guidelines in order to improve a concussion detection algorithm previously developed by Jan Medical, Inc.The primary endpoint is to enroll and record BrainPulse signals from 500 subjects with a suspected concussion. To gather sufficiently diverse data, at least 300 participants will have had a confirmed diagnosis of concussion. The data will be used to improve the algorithm for aiding in the diagnosis of concussion.	Through study completion, expected to be 6 months
Secondary	Average number of days the signal pattern seen within BrainPulse recordings from confirmed concussed subjects from the initial recording persist over the course of the 21 day follow up period.	The secondary endpoint is to assess the differences in BrainPulse recordings between the initial visit and each subsequent follow-up visit to better understand the recovery process post concussion.	Through study completion, expected to be 1 year]